Ishita Drugs and Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
For the six months, sales was INR 57.85 million compared to INR 61 million a year ago. Revenue was INR 58.74 million compared to INR 61.41 million a year ago. Net income was INR 2.75 million compared to INR 2.42 million a year ago. Basic earnings per share from continuing operations was INR 0.921 compared to INR 0.809 a year ago. Diluted earnings per share from continuing operations was INR 0.921 compared to INR 0.809 a year ago.